Loading data for BYSI — first visit, this takes a few seconds.
BeyondSpring Inc. (BYSI)
NasdaqCM: BYSI
· Real-Time Price · USD
0.67
+0.03 (4.69%)
At close: Aug 28, 2026, 8:00 PM
0.64
-3.76%
After-hours: 6:47 PM
The price, the headline numbers and the latest news, in one place.
BeyondSpring Inc. (BYSI) Stock Price, Analysis & Data
4.69% (1D)
No data available
| Bid | 0.44 |
| Market Cap | 27.36M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.29M |
| 0.12 | |
| -0.19 | |
| n/a | |
| -1.42 | |
| P/B (ttm) | -0.77 |
| P/S (ttm) | n/a |
| Earnings Date | Nov 12, 2026 |
| Ask | 0.81 |
| Volume | 113,572 |
| Avg. Volume (20D) | 674,819 |
| Open | 0.61 |
| Previous Close | 0.64 |
| Day's Range | 0.61 - 0.67 |
| 52-Week Range | 0.57 - 2.44 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About BYSI
BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform. The company's lead asset is Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (...
Industry Biotechnology
Sector Healthcare
IPO Date Mar 9, 2017
Employees 44
Stock Exchange NasdaqCM
Ticker Symbol BYSI
Website https://beyondspringpharma.com
Financial Performance
In 2025, BeyondSpring's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -1.01M, a decrease of -90.96%.
Financial StatementsEarnings Surprise
BeyondSpring has released their quarterly earnings on Apr 14, 2022:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.24 misses estimates by -0.02, with 53.85% YoY growth.
BeyondSpring Inc. is scheduled to release its earnings on Nov 12, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
